1.
Pregnant Rats With 5/6 Nephrectomy Have Normal Volume Expansion Despite Lower Renin and Kallikrein
by Salas, Sofía P
Hypertension (Dallas, Tex. 1979), 2003-10, Vol.42 (4, Part 2), p.744-748

2.
Dopaminergic Abnormalities in Hypertension Associated With Moderate Renal Insufficiency
by Kuchel, Otto G
Hypertension (Dallas, Tex. 1979), 1994-01, Vol.23 (1 Suppl I), p.I-240-I-245

3.
Urinary magnesium excretion and risk of hypertension. The prevention of renal and vascular end-stage disease study
by Joosten, M.M
Hypertension (Dallas, Tex. 1979), 2013, Vol.61 (6), p.1161-1167

4.
Aortic Stiffness Is Independently Associated With Rate of Renal Function Decline in Chronic Kidney Disease Stages 3 and 4
by Ford, Martin L
Hypertension (Dallas, Tex. 1979), 2010-05, Vol.55 (5), p.1110-1115

5.
Blood Pressure-Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease
by Dhaun, Neeraj
Hypertension (Dallas, Tex. 1979), 2009-07, Vol.54 (1), p.113-119

6.
Urinary Potassium Excretion and Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study
by Kieneker, Lyanne M
Hypertension (Dallas, Tex. 1979), 2014-10, Vol.64 (4), p.769-776

7.
Association Between Urinary Sodium, Creatinine, Albumin, and Long-Term Survival in Chronic Kidney Disease
by McQuarrie, Emily P
Hypertension (Dallas, Tex. 1979), 2014-07, Vol.64 (1), p.111-117

8.
Enhanced Nitric Oxide Inactivation and Protein Nitration by Reactive Oxygen Species in Renal Insufficiency
by Vaziri, Nosratola D
Hypertension (Dallas, Tex. 1979), 2002-01, Vol.39 (1), p.135-141

9.
Lowered magnesium in hypertension
by Kisters, Klaus
Hypertension (Dallas, Tex. 1979), 2013-10, Vol.62 (4), p.e19-e19

10.
Response to Lowered Magnesium in Hypertension
by Joosten, Michel M
Hypertension (Dallas, Tex. 1979), 2013-10, Vol.62 (4), p.e20-e20

11.
Renal and Metabolic Clearance of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP) During Angiotensin-Converting Enzyme Inhibition in Humans
by Azizi, Michel
Hypertension (Dallas, Tex. 1979), 1999-03, Vol.33 (3), p.879-886

12.
Nitric Oxide Metabolism in Erythropoietin-Induced Hypertension: Effect of Calcium Channel Blockade
by Ni, Zhenmin
Hypertension (Dallas, Tex. 1979), 1998-10, Vol.32 (4), p.724-729

13.
Comparison of Converting Enzyme Inhibitor and Calcium Channel Blocker in Hypertensive Glomerular Injury
by Tolins, Jonathan P
Hypertension (Dallas, Tex. 1979), 1990-10, Vol.16 (4), p.452-461

14.
Sodium Balance in Renal Failure: A Comparison of Patients with Normal Subjects Under Extremes of Sodium Intake
by KOOMANS, HEIN A
Hypertension (Dallas, Tex. 1979), 1985-09, Vol.7 (5), p.714-721

15.
Atrial Natriuretic Factor in Mild to Moderate Chronic Renal Failure
by SUDA, SUSANNE
Hypertension (Dallas, Tex. 1979), 1988-05, Vol.11 (5), p.483-490

16.
Blood Concentration and Urinary Excretion of Captopril (SQ 14,225) in Patients with Chronic Renal Failure
by ONOYAMA, KAORU
Hypertension (Dallas, Tex. 1979), 1981-07, Vol.3 (4), p.456-459

17.
Malignant hypertension: a syndrome accompanied by plasmatic diminution of low and high molecular weight kininogens
by Ribeiro, A B
Hypertension (Dallas, Tex. 1979), 1983-11, Vol.5 (6 Pt 3), p.V158-V162
